Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 11 Sept, 09:00 pm
Merck & Co., Inc. (NYSE:MRK) is strategically investing in new products and its research pipeline to ensure continued growth as its key cancer drug, KEYTRUDA, approaches market exclusivity loss. Despite a recent daily dip, Merck & Co., Inc. shares demonstrated strong monthly perf
Adobe Stock Price Target: UBS Maintains $255 Target After Record Q3 Results UBS maintained a Neutral rating and a $255 price target for Adobe, representing approximately 2.5% upside from its September 10 closing price. Adobe (NASDAQ: ADBE) reported record third-quarter revenue of
Investment firm UBS downgraded NuScale Power (NYSE: SMR) to a "Sell" rating, impacting its stock performance. The downgrade reflects a broader negative sentiment and market trends within the advanced nuclear industry , affecting competitors as well. Despite recent stock declines,
Alliance Entertainment (NASDAQ: AENT) Reports Strong Q4 Revenue and Improved Fiscal 2026 Margins Alliance Entertainment reported fourth-quarter revenue of $268.10 million , exceeding the estimate of $234.95 million . The company recorded quarterly earnings per share of $0.13 , co
Morgan Stanley downgraded Novo Nordisk (NYSE: NVO) to "Underweight," setting a price target of $40.00 , implying a potential 9.11% downside from its then-current stock price of $44.01 . The pharmaceutical giant's shares have recently underperformed, with a 1.23% daily decline and
LightPath Technologies reported significant revenue growth , with fourth-quarter revenue reaching $21.16 million , a 73% increase year-over-year, and full-year revenue growing 93% to $71.70 million . Despite strong sales, the company posted an earnings per share (EPS) of -$0.02 ,
Strong EPS Beat: Frequency Electronics, Inc. reported earnings per share of $0.41 , significantly beating the analyst consensus estimate of $0.15 . Record Revenue Growth: The company achieved record revenue of $23.50 million in Q1 FY2027, a 70% increase year-over-year, driven by
Champions Oncology, Inc. (NASDAQ: CSBR) Reports Q1 Revenue Growth and Improved Adjusted EBITDA Champions Oncology, Inc. reported adjusted earnings per share of $0.05 , exceeding the consensus estimate of a $0.01 loss per share . Revenue increased 8.8% year over year, driven prima
Robust Financial Performance: Descartes Systems Group met analyst expectations for EPS and surpassed revenue estimates, showcasing strong quarterly results. Strategic Expansion: The company's acquisition of Extensiv significantly enhances its offerings in the growing e-commerce f
Investment firm Goldman Sachs has maintained its Sell rating for JetBlue and lowered its price target to $4.00 from $4.50 . JetBlue reduced its third-quarter capacity-growth outlook due to operational challenges, including adverse weather and rising fuel costs. Elevated oil price
Zumiez missed Q3 2026 earnings and revenue estimates, reporting an EPS of -$0.17 and revenue of $208.96 million . The weaker performance was attributed to "continued softness in footwear" and "lower traffic levels" in the U.S., leading to a 2.1% decline in comparable sales. Zumie
KeyBanc initiated an Underweight rating on CF Industries with a price target of $115.00 , significantly below its trading price of $135.11 . Despite strong year-over-year growth in Earnings per share ( 99.6% to $4.73 ) and net sales ( 17.6% to $2.22 billion ), the company missed
Earnings Beat: Fevertree Drinks PLC's latest earnings per share (EPS) of $0.15 surpassed analyst estimates. Strong Profitability: The company reported an adjusted EBITDA of £20.10 million , exceeding expectations. Geographic Expansion: Significant revenue growth was observed acro
KeyBanc's "Sector Weight" Rating: Analyst firm KeyBanc initiated coverage on Air Products and Chemicals (NYSE: APD) with a neutral "Sector Weight" rating, indicating expected performance in line with its sector. Strong Profitability Despite Neutral Outlook: Air Products and Chemi
RH (NYSE: RH) defied low expectations, reporting significantly stronger-than-anticipated Q2 earnings and revenue. The company's earnings per share (EPS) of $2.70 dramatically surpassed the analyst consensus of $0.38 . RH also posted robust revenue of $922.20 million , exceeding t
Navan (NASDAQ: NAVN) declined despite an earnings beat as investors focused on rising expenses and expectations for a larger guidance increase. Biohaven (NYSE: BHVN) fell after the FDA paused new enrollment in trials of its experimental epilepsy drug. Weak guidance and the decisi
Tenon Medical (NASDAQ: TNON) surged after eliminating convertible debt that could have diluted existing shareholders. Strong earnings drove the gain in Wealthfront (NASDAQ: WLTH) . The advances in Digital Brands Group (NASDAQ: DBGI) and PicoCELA (NASDAQ: PCLA) occurred without cl
Kroger's Upcoming Earnings: Analysts anticipate earnings per share between $1.05 and $1.06 on revenues of approximately $34.64 billion to $34.68 billion , highlighting key financial performance metrics. Operational Challenges: Despite strong digital and fresh category momentum, t
Headlines provided by Investing.com